In addition to Smarcad1, we identify candidate bacterial species crucial for the phenotype severity of colitis, highlighting their potential as targets for pharmacological and probiotic treatment of intestinal inflammatory diseases. This evidence concerns the gene SMARCAD1 and colitis.